Trial intelligence / Profile preview

Levothyroxine versus placebo in subclinical hypothyroidism

IRCT20171129037677N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in hypothyroidism comparing Levothyroxine recipients with Placebo recipients (2 arms). Primary endpoint: Serum osteocalcin level. Started Sep 2017; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on IRCT20171129037677N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171129037677N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call